In a filing, 10x Genomics Inc revealed its Chief Executive Officer Saxonov Serge unloaded Company’s shares for reported $77540.0 on May 22 ’25. In the deal valued at $8.30 per share,9,343 shares were sold. As a result of this transaction, Saxonov Serge now holds 1,083,625 shares worth roughly $11.28 million.
Then, Hindson Benjamin J. sold 7,485 shares, generating $62,120 in total proceeds. Upon selling the shares at $8.30, the insider now owns 448,374 shares.
Before that, Taich Adam sold 4,044 shares. 10x Genomics Inc shares valued at $33,562 were divested by the Chief Financial Officer at a price of $8.30 per share. As a result of the transaction, Taich Adam now holds 331,588 shares, worth roughly $3.45 million.
Leerink Partners downgraded its 10x Genomics Inc [TXG] rating to a Market perform from a an Outperform in a research note published on February 13, 2025; the price target was decreased to $12 from $25. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early September with a ‘”an Outperform”‘ rating. Jefferies also remained covering TXG and has increased its forecast on July 22, 2024 with a “Buy” recommendation from previously “Hold” rating. JP Morgan revised its rating on July 18, 2024. It rated TXG as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of TXG
On Friday, 10x Genomics Inc [NASDAQ:TXG] saw its stock fall -1.56% to $10.41. Over the last five days, the stock has gained 10.56%. 10x Genomics Inc shares have fallen nearly -27.47% since the year began. Nevertheless, the stocks have fallen -51.74% over the past one year. While a 52-week high of $24.76 was reached on 01/13/25, a 52-week low of $6.78 was recorded on 04/07/25.
Levels Of Support And Resistance For TXG Stock
The 24-hour chart illustrates a support level at 10.21, which if violated will result in even more drops to 10.01. On the upside, there is a resistance level at 10.64. A further resistance level may holdings at 10.87.
How much short interest is there in 10x Genomics Inc?
A steep rise in short interest was recorded in 10x Genomics Inc stocks on 2025-05-30, growing by 0.52 million shares to a total of 16.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 15.5 million shares. There was a rise of 3.24%, which implies that there is a positive sentiment for the stock.
